Norman D. Schwartz - 01 Sep 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: Chairman, President, and CEO, Director, 10%+ Owner
Signature: /s/ Norman Schwartz
Issuer symbol: BIO
Transactions as of: 01 Sep 2023
Net transactions value: $0
Form type: 4
Filing time: 06 Sep 2023, 12:50:36 UTC
Previous filing: 28 Aug 2023
Next filing: 02 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BIO	Bio-Rad A Common Stock						432,920	01 Sep 2023	Direct
holding	BIO	Bio-Rad B Common Stock						345,300	01 Sep 2023	Direct
holding	BIO	Bio-Rad B Common Stock						12,900	01 Sep 2023	By Spouse	F1
holding	BIO	Bio-Rad B Common Stock						4,060,054	01 Sep 2023	By Blue Raven Partners, L.P.	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Restricted Stock Units	Award	$0	+12,020		$0.000000	12,020	01 Sep 2023	Bio-Rad A Common Stock	12,020	$0.000000	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person disclaims beneficial ownership of these shares.
F2	The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4	The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.